Charles River Laboratories Announces Third-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Charles River Laboratories (CRL) Tops Q3 EPS by 6c, Updates Guidance
November 6, 2019 7:13 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.69, $0.06 better than the analyst estimate of $1.63. Revenue for the quarter came in at $668 million versus the consensus estimate of $672.74 million.
GUIDANCE:
Charles River Laboratories sees FY2019 EPS of $6.50-$6.60, versus... More
